A 37-year-old man previously treated with monotherapy for latent tuberculosis develops new-onset cough, night sweats and fever. He produces a sputum sample that is positive for acid-fast bacilli. Resistance testing of his isolated bacteria finds a mutation in the DNA-dependent RNA polymerase. To which of the following antibiotics might this patient's infection be resistant?
Q62
A 42-year-old homeless man presents to the emergency department complaining of pain in his right knee and fever. The patient is having difficulty walking and looks visibly uncomfortable. On examination, he is disheveled but his behavior is not erratic. The patient’s right knee is erythematous, edematous, and warm, with evidence of a 3 cm wound that is weeping purulent fluid. The patient has a decreased range of motion secondary to pain and swelling. The wound is cultured and empiric antibiotic therapy is initiated. Four minutes into the patient’s antibiotic therapy, he develops a red, pruritic rash on his face and neck. What is the most likely antibiotic this patient is being treated with?
Q63
A 26-year-old African American woman presents to the clinic with burning upon urination. The patient describes increased frequency, urgency, and a painful sensation at the urethra when urinating for the past 3 days. She also reports increased vaginal discharge and abnormal odor during the same time. The patient denies fever, flank pain, or hematuria (though the patient does report a dark brown color of the urine). Her past medical history is significant for Crohn disease that is controlled with sulfasalazine. Vital signs are within normal limits. What is the definitive treatment of the described condition?
Q64
A 46-year-old man presents to his primary care provider for an ulcerating skin lesion on his leg for the past week. He says that the week prior he slipped while hiking and scraped his left leg. Over the course of the next week, he noticed redness and swelling of the scraped area and the development of a nodule that eventually ulcerated. On exam, his temperature is 99.5°F (37.5°C), blood pressure is 136/92 mmHg, pulse is 88/min, and respirations are 12/min. Over his left lateral leg is an erythematous patch with a 2-cm nodule with central ulceration. Staining of a sample from the nodule demonstrates gram-positive organisms that are also weakly acid-fast. Morphologically, the organism appears as branching filaments. Which of the following should be used to treat this infection?
Q65
A 67-year-old man presents to the emergency department for altered mental status. The patient is a member of a retirement community and was found to have a depressed mental status when compared to his baseline. The patient has a past medical history of Alzheimer dementia and diabetes mellitus that is currently well-controlled. His temperature is 103°F (39.4°C), blood pressure is 157/108 mmHg, pulse is 110/min, respirations are 17/min, and oxygen saturation is 98% on room air. Physical exam is notable for a somnolent elderly man who is non-verbal; however, his baseline status is unknown. Musculoskeletal exam of the patient’s lower extremities causes him to recoil in pain. Head and neck exam reveals a decreased range of motion of the patient's neck. Flexion of the neck causes discomfort in the patient. No lymphadenopathy is detected. Basic labs are ordered and a urine sample is collected. Which of the following is the best next step in management?
Q66
A 31-year-old female with a bacterial infection is prescribed a drug that binds the dipeptide D-Ala-D-Ala. Which of the following drugs was this patient prescribed?
Q67
A 42-year-old man with hypertension and type 2 diabetes mellitus is admitted to the hospital because of swelling and redness of the left leg for 3 days. He has chills and malaise. He is treated with intravenous clindamycin for 7 days. On the 8th day at the hospital, he has profuse, foul-smelling, and watery diarrhea. He has nausea and intermittent abdominal cramping. His temperature is 38°C (100.4°F), pulse is 97/min, and blood pressure is 110/78 mm Hg. Bowel sounds are hyperactive. Abdominal examination shows mild tenderness in the left lower quadrant. Rectal examination shows no abnormalities. His hemoglobin concentration is 14.3 g/dL, leukocyte count is 12,300/mm3, and C-reactive protein concentration is 62 mg/L (N=0.08–3.1). After discontinuing clindamycin, which of the following is the most appropriate pharmacotherapy for this patient's condition?
Q68
An 89-year-old woman presents to clinic complaining of a cough. She reports that she has never had a cough like this before. She takes a deep breath and then coughs multiple times, sometimes so much that she vomits. When she tries to catch her breath after a coughing spell, she has difficulty. She reports the cough has persisted for 3 weeks and usually comes in fits. Vital signs are stable. Physical examination is benign. You send cultures and a PCR of her secretions, both of which come back positive for the organism you had suspected. You tell her to stay away from her grandchildren because her illness may be fatal in infants. You also start her on medication. The illness affecting this patient would be best treated by a class of antibiotics...
Q69
A 29-year-old woman comes to the physician because of a 4-day history of fever with chills, nausea, myalgias, and malaise. One week ago, she returned from a trip to Rhode Island, where she participated in a month-long program to become an assistant park ranger. Laboratory studies show a leukocyte count of 1,400/mm3. A peripheral blood smear shows dark purple, mulberry-like inclusions inside the granulocytes. A presumptive diagnosis is made and pharmacotherapy is initiated with the drug of choice for this condition. The bacteriostatic effect of this drug is most likely due to inhibition of which of the following processes?
Q70
A 13-year-old boy is brought to the emergency department because of a 2-day history of fever, headache, and irritability. He shares a room with his 7-year-old brother, who does not have any symptoms. The patient appears weak and lethargic. His temperature is 39.1°C (102.4°F) and blood pressure is 99/60 mm Hg. Physical examination shows several purple spots over the trunk and extremities. A lumbar puncture is performed. Gram stain of the cerebrospinal fluid shows numerous gram-negative diplococci. Administration of which of the following is most likely to prevent infection of the patient's brother at this time?
Antibiotics US Medical PG Practice Questions and MCQs
Question 61: A 37-year-old man previously treated with monotherapy for latent tuberculosis develops new-onset cough, night sweats and fever. He produces a sputum sample that is positive for acid-fast bacilli. Resistance testing of his isolated bacteria finds a mutation in the DNA-dependent RNA polymerase. To which of the following antibiotics might this patient's infection be resistant?
A. Isoniazid
B. Rifampin (Correct Answer)
C. Pyrazinamide
D. Streptomycin
E. Ethambutol
Explanation: **Rifampin is correct**
- A mutation in the **DNA-dependent RNA polymerase** gene (*rpoB*) is the primary mechanism of resistance to **rifampin**.
- **Rifampin** specifically targets bacterial **RNA polymerase**, inhibiting RNA synthesis.
*Isoniazid is incorrect*
- Resistance to **isoniazid** is typically associated with mutations in the **katG** gene (encoding catalase-peroxidase) or the **inhA** gene (involved in mycolic acid synthesis).
- It does not directly affect **DNA-dependent RNA polymerase**.
*Pyrazinamide is incorrect*
- Resistance to **pyrazinamide** is primarily linked to mutations in the **pncA** gene, which encodes pyrazinamidase, an enzyme required to activate pyrazinamide.
- This drug's mechanism of action and resistance pathways are unrelated to **RNA polymerase**.
*Streptomycin is incorrect*
- Resistance to **streptomycin**, an aminoglycoside, primarily involves mutations in the **rrs** gene (16S rRNA) or the **rpsL** gene (ribosomal protein S12).
- It works by inhibiting bacterial protein synthesis and is not directly related to **RNA polymerase**.
*Ethambutol is incorrect*
- Resistance to **ethambutol** is mainly due to mutations in the **embB** gene, which encodes arabinosyl transferases involved in arabinogalactan synthesis in the cell wall.
- Its mechanism of action involves inhibiting cell wall synthesis, not **RNA polymerase**.
Question 62: A 42-year-old homeless man presents to the emergency department complaining of pain in his right knee and fever. The patient is having difficulty walking and looks visibly uncomfortable. On examination, he is disheveled but his behavior is not erratic. The patient’s right knee is erythematous, edematous, and warm, with evidence of a 3 cm wound that is weeping purulent fluid. The patient has a decreased range of motion secondary to pain and swelling. The wound is cultured and empiric antibiotic therapy is initiated. Four minutes into the patient’s antibiotic therapy, he develops a red, pruritic rash on his face and neck. What is the most likely antibiotic this patient is being treated with?
A. Gentamicin
B. Linezolid
C. Penicillin G
D. Erythromycin
E. Vancomycin (Correct Answer)
Explanation: ***Vancomycin***
- The rapid development of a **red, pruritic rash** on the face and neck shortly after starting antibiotic therapy for a systemic infection (likely **septic arthritis** given the symptoms) is highly characteristic of **Red Man Syndrome**.
- **Red Man Syndrome** is a pseudoallergic reaction caused by rapid infusion of **vancomycin**, leading to **histamine release**.
*Gentamicin*
- **Gentamicin** is an aminoglycoside antibiotic used for gram-negative infections, but it is not typically associated with a rapid-onset facial rash.
- Its primary adverse effects include **ototoxicity** and **nephrotoxicity**, which develop with prolonged use rather than acute infusion.
*Linezolid*
- **Linezolid** is an oxazolidinone antibiotic primarily used for resistant gram-positive bacteria like MRSA.
- While it can cause side effects like **myelosuppression** and **serotonin syndrome** (if co-administered with serotonergic drugs), it does not typically cause a rapid, prominent facial rash.
*Penicillin G*
- **Penicillin G** is a beta-lactam antibiotic that can cause allergic reactions, but these are typically **IgE-mediated hypersensitivity reactions** (e.g., anaphylaxis, urticaria, angioedema) and less commonly present as a specific "red man" flush.
- The rash associated with penicillin allergy is usually a more widespread **maculopapular rash** or urticaria, not localized to the face and neck in this specific fashion minutes after administration.
*Erythromycin*
- **Erythromycin** is a macrolide antibiotic whose common side effects include **gastrointestinal upset** (e.g., nausea, vomiting, abdominal pain) and QT prolongation.
- It is not known to cause a rapid-onset, pruritic facial rash like the one described.
Question 63: A 26-year-old African American woman presents to the clinic with burning upon urination. The patient describes increased frequency, urgency, and a painful sensation at the urethra when urinating for the past 3 days. She also reports increased vaginal discharge and abnormal odor during the same time. The patient denies fever, flank pain, or hematuria (though the patient does report a dark brown color of the urine). Her past medical history is significant for Crohn disease that is controlled with sulfasalazine. Vital signs are within normal limits. What is the definitive treatment of the described condition?
A. Surgery
B. IV ceftriaxone
C. Increase in sulfasalazine dose
D. IM ceftriaxone and oral azithromycin (Correct Answer)
E. Bactrim
Explanation: ***IM ceftriaxone and oral azithromycin***
- This combination is the recommended treatment for **gonorrhea (IM ceftriaxone)** and presumptive or confirmed **chlamydia (oral azithromycin)**, which are common causes of urethritis and cervicitis, fitting the patient's symptoms of dysuria, frequency, urgency, and vaginal discharge.
- The patient's symptoms are suggestive of a **sexually transmitted infection (STI)** causing urethritis and cervicitis, rather than a typical uncomplicated urinary tract infection (UTI) due to the presence of vaginal discharge and odor.
- The **dark brown urine** is likely due to **sulfasalazine**, which commonly causes orange-brown discoloration of urine and body fluids, not hematuria.
*Surgery*
- Surgery is typically reserved for **complications** of STIs or UTIs, such as abscesses or structural abnormalities, which are not indicated by the patient's current presentation.
- While Crohn disease can sometimes lead to fistulas that might require surgery, the described urinary symptoms and vaginal discharge point more directly to an infection rather than a primary surgical issue.
*IV ceftriaxone*
- **Intravenous (IV) ceftriaxone** is used in cases of severe or disseminated infections, such as **gonococcal bacteremia** or **meningitis**, or when oral treatment is not feasible.
- The patient's current presentation does not suggest a severe or life-threatening infection requiring IV administration; intramuscular (IM) administration is sufficient for uncomplicated urogenital gonorrhea.
*Increase in sulfasalazine dose*
- **Sulfasalazine** is an anti-inflammatory drug used to manage **Crohn's disease** and will not treat bacterial infections causing urethritis or cervicitis.
- Increasing its dose would not address the patient's symptoms of dysuria, frequency, urgency, or vaginal discharge, as these are infectious in nature.
*Bactrim*
- **Bactrim (trimethoprim-sulfamethoxazole)** is a common antibiotic for **uncomplicated UTIs** caused by bacteria like E. coli.
- It is not effective against *Neisseria gonorrhoeae* and is showing increasing resistance against *Chlamydia trachomatis*, making it an inappropriate choice for suspected STIs.
Question 64: A 46-year-old man presents to his primary care provider for an ulcerating skin lesion on his leg for the past week. He says that the week prior he slipped while hiking and scraped his left leg. Over the course of the next week, he noticed redness and swelling of the scraped area and the development of a nodule that eventually ulcerated. On exam, his temperature is 99.5°F (37.5°C), blood pressure is 136/92 mmHg, pulse is 88/min, and respirations are 12/min. Over his left lateral leg is an erythematous patch with a 2-cm nodule with central ulceration. Staining of a sample from the nodule demonstrates gram-positive organisms that are also weakly acid-fast. Morphologically, the organism appears as branching filaments. Which of the following should be used to treat this infection?
A. Streptomycin
B. Clindamycin
C. Doxycycline
D. Penicillin
E. Trimethoprim-sulfamethoxazole (Correct Answer)
Explanation: ***Trimethoprim-sulfamethoxazole***
- The patient's symptoms (nodule on the leg after skin trauma, progressing to ulceration) and the microbiology findings (gram-positive, weakly acid-fast, branching filaments) are highly suggestive of a **Nocardia infection**.
- **Trimethoprim-sulfamethoxazole (TMP-SMX)** is the antimicrobial agent of choice for treating Nocardiosis, including both cutaneous and disseminated disease.
- Treatment typically requires prolonged therapy (3-12 months depending on severity and immune status).
*Streptomycin*
- **Streptomycin** is an aminoglycoside antibiotic primarily used to treat **tuberculosis** and some other severe bacterial infections.
- It is not considered first-line therapy for Nocardia infections.
*Clindamycin*
- **Clindamycin** is effective against many gram-positive bacteria and anaerobes.
- However, it is not the preferred treatment for **Nocardia** infections, which have a distinct susceptibility profile.
*Doxycycline*
- **Doxycycline** is a broad-spectrum tetracycline antibiotic often used for atypical infections, skin infections, and Lyme disease.
- While it may have some activity against Nocardia, it is not the **first-line agent** for severe or localized Nocardiosis.
- Alternative agents for TMP-SMX-allergic patients or severe disease include imipenem, amikacin, or linezolid.
*Penicillin*
- **Penicillin** is effective against a wide range of gram-positive bacteria, but **Nocardia species** are typically resistant to penicillin.
- The branching filament morphology characteristic of Nocardia makes penicillin an inappropriate choice.
Question 65: A 67-year-old man presents to the emergency department for altered mental status. The patient is a member of a retirement community and was found to have a depressed mental status when compared to his baseline. The patient has a past medical history of Alzheimer dementia and diabetes mellitus that is currently well-controlled. His temperature is 103°F (39.4°C), blood pressure is 157/108 mmHg, pulse is 110/min, respirations are 17/min, and oxygen saturation is 98% on room air. Physical exam is notable for a somnolent elderly man who is non-verbal; however, his baseline status is unknown. Musculoskeletal exam of the patient’s lower extremities causes him to recoil in pain. Head and neck exam reveals a decreased range of motion of the patient's neck. Flexion of the neck causes discomfort in the patient. No lymphadenopathy is detected. Basic labs are ordered and a urine sample is collected. Which of the following is the best next step in management?
A. Ceftriaxone and vancomycin
B. CT scan of the head
C. Ceftriaxone, vancomycin, ampicillin, and steroids (Correct Answer)
D. Ceftriaxone, vancomycin, and ampicillin
E. Trimethoprim-sulfamethoxazole
Explanation: ***Ceftriaxone, vancomycin, ampicillin, and steroids***
- The patient presents with **fever**, **altered mental status**, and **nuchal rigidity**, highly suggestive of **bacterial meningitis**.
- Per **IDSA guidelines**, empiric treatment for bacterial meningitis in adults ≥50 years includes: **dexamethasone** (given before or with the first dose of antibiotics) + **ceftriaxone** + **vancomycin** + **ampicillin**.
- **Dexamethasone** reduces inflammation, mortality, and neurological complications, especially in pneumococcal meningitis.
- This regimen provides broad-spectrum coverage: **_Streptococcus pneumoniae_** (ceftriaxone, vancomycin), **_Neisseria meningitidis_** (ceftriaxone), and **_Listeria monocytogenes_** (ampicillin).
*Ceftriaxone, vancomycin, and ampicillin*
- While this provides appropriate antibiotic coverage for the likely pathogens in elderly patients with meningitis, it is **incomplete** without steroids.
- **Dexamethasone should be administered before or with the first dose of antibiotics**, not delayed or omitted.
- Omitting steroids increases the risk of adverse neurological outcomes.
*Trimethoprim-sulfamethoxazole*
- This antibiotic is primarily used for urinary tract infections, certain skin infections, and **_Pneumocystis jirovecii_ pneumonia**.
- It does not provide adequate coverage for the common bacterial causes of meningitis, nor does it achieve sufficient CNS penetration for empiric treatment.
*Ceftriaxone and vancomycin*
- This combination is appropriate for meningitis in younger adults (< 50 years).
- However, in older adults (≥ 50 years), there is an increased risk of **_Listeria monocytogenes_** infection, which this regimen does not cover.
- Additionally, steroids are missing from this regimen.
*CT scan of the head*
- While a CT scan of the head is often performed to rule out **mass effect** or **contraindications to lumbar puncture** (e.g., focal neurological deficits, papilledema), it should **not delay the administration of empiric antibiotics and steroids**.
- In suspected bacterial meningitis, treatment should be initiated immediately; imaging can be performed afterward if needed.
Question 66: A 31-year-old female with a bacterial infection is prescribed a drug that binds the dipeptide D-Ala-D-Ala. Which of the following drugs was this patient prescribed?
A. Polymyxin B
B. Nalidixic acid
C. Chloramphenicol
D. Vancomycin (Correct Answer)
E. Penicillin
Explanation: ***Vancomycin***
- **Vancomycin** is a glycopeptide antibiotic that directly binds to the **D-Ala-D-Ala** terminus of peptidoglycan precursors.
- This binding prevents the **transpeptidation** and **transglycosylation** steps required for bacterial cell wall synthesis, leading to cell lysis.
*Polymyxin B*
- **Polymyxins** are **cationic detergents** that disrupt the integrity of the bacterial **outer membrane** in Gram-negative bacteria.
- They bind to **lipopolysaccharide (LPS)**, causing increased permeability and leakage of intracellular components, but do not target D-Ala-D-Ala.
*Nalidixic acid*
- **Nalidixic acid** is a **quinolone antibiotic** that inhibits bacterial **DNA gyrase (topoisomerase II)** and **topoisomerase IV**.
- Its mechanism of action involves preventing DNA replication and transcription, not cell wall synthesis or D-Ala-D-Ala binding.
*Chloramphenicol*
- **Chloramphenicol** is an antibiotic that inhibits bacterial **protein synthesis** by binding to the **50S ribosomal subunit**.
- It prevents the formation of **peptide bonds** by inhibiting peptidyl transferase, an entirely different target from D-Ala-D-Ala in the cell wall.
*Penicillin*
- **Penicillin** is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to and inactivating **penicillin-binding proteins (PBPs)**.
- PBPs are **transpeptidases** involved in cross-linking peptidoglycan, but penicillin does not directly bind to the D-Ala-D-Ala substrate itself; instead, it prevents the enzymes from using it.
Question 67: A 42-year-old man with hypertension and type 2 diabetes mellitus is admitted to the hospital because of swelling and redness of the left leg for 3 days. He has chills and malaise. He is treated with intravenous clindamycin for 7 days. On the 8th day at the hospital, he has profuse, foul-smelling, and watery diarrhea. He has nausea and intermittent abdominal cramping. His temperature is 38°C (100.4°F), pulse is 97/min, and blood pressure is 110/78 mm Hg. Bowel sounds are hyperactive. Abdominal examination shows mild tenderness in the left lower quadrant. Rectal examination shows no abnormalities. His hemoglobin concentration is 14.3 g/dL, leukocyte count is 12,300/mm3, and C-reactive protein concentration is 62 mg/L (N=0.08–3.1). After discontinuing clindamycin, which of the following is the most appropriate pharmacotherapy for this patient's condition?
A. Intravenous vancomycin
B. Oral fidaxomicin (Correct Answer)
C. Intravenous metronidazole
D. Oral metronidazole
E. Oral rifaximin
Explanation: ***Oral fidaxomicin***
- The patient's presentation with profuse, foul-smelling, watery diarrhea, abdominal cramping, and fever after prolonged antibiotic use (clindamycin) is highly suggestive of **Clostridioides difficile infection (CDI)**.
- **Oral fidaxomicin** is a first-line agent for initial CDI episodes with **superior efficacy** in reducing recurrence rates compared to metronidazole and similar cure rates to oral vancomycin. It is preferred due to its **narrow spectrum**, **bactericidal activity against C. difficile**, and **minimal disruption to normal colonic flora**.
- Current IDSA/SHEA guidelines recommend fidaxomicin or oral vancomycin as first-line therapy for initial CDI episodes.
*Intravenous vancomycin*
- **Intravenous vancomycin** has poor penetration into the GI tract and is therefore **ineffective for C. difficile infection (CDI)**, which is an intraluminal infection.
- Oral vancomycin is effective for CDI, but intravenous administration will not treat the infection.
*Intravenous metronidazole*
- **Intravenous metronidazole** has limited efficacy in treating **Clostridioides difficile infection (CDI)** as first-line therapy.
- While it achieves some colonic concentration even when given intravenously, oral agents (fidaxomicin or vancomycin) are preferred for initial episodes.
- IV metronidazole may be used as adjunctive therapy in fulminant cases with ileus when oral agents cannot reach the colon.
*Oral metronidazole*
- **Oral metronidazole** was previously used for non-severe CDI but is **no longer recommended as first-line therapy** per updated IDSA/SHEA guidelines due to inferior cure rates and higher recurrence rates compared to vancomycin and fidaxomicin.
- It may be considered only when fidaxomicin and vancomycin are unavailable.
*Oral rifaximin*
- **Oral rifaximin** is sometimes used as **adjunctive therapy following standard treatment** to prevent recurrent C. difficile infection (CDI).
- It is **not recommended as initial monotherapy** for an active CDI episode.
Question 68: An 89-year-old woman presents to clinic complaining of a cough. She reports that she has never had a cough like this before. She takes a deep breath and then coughs multiple times, sometimes so much that she vomits. When she tries to catch her breath after a coughing spell, she has difficulty. She reports the cough has persisted for 3 weeks and usually comes in fits. Vital signs are stable. Physical examination is benign. You send cultures and a PCR of her secretions, both of which come back positive for the organism you had suspected. You tell her to stay away from her grandchildren because her illness may be fatal in infants. You also start her on medication. The illness affecting this patient would be best treated by a class of antibiotics...
A. that is known to cause nephrotoxicity and ototoxicity
B. that may cause tooth discoloration and inhibit bone growth in children
C. that may prolong the QT interval (Correct Answer)
D. that may cause gray baby syndrome in premature infants
E. that may cause a disulfiram-like reaction when taken with alcohol
Explanation: ***that may prolong the QT interval***
- The patient's symptoms (paroxysms of cough followed by vomiting, difficulty catching breath, persistence for 3 weeks) are classic for **pertussis (whooping cough)**, caused by *Bordetella pertussis*.
- Macrolide antibiotics, such as **azithromycin** or **erythromycin**, are the primary treatment for pertussis and are known to prolong the **QT interval**.
*that is known to cause nephrotoxicity and ototoxicity*
- This adverse effect profile is characteristic of **aminoglycosides** (e.g., gentamicin, tobramycin).
- Aminoglycosides are **not the primary treatment** for pertussis.
*that may cause tooth discoloration and inhibit bone growth in children*
- These side effects are associated with **tetracyclines** (e.g., doxycycline, tetracycline).
- Tetracyclines are **not the first-line treatment** for pertussis, especially in the context of preventing transmission to infants.
*that may cause gray baby syndrome in premature infants*
- **Chloramphenicol** is associated with **gray baby syndrome** due to impaired glucuronidation in neonates.
- Chloramphenicol is **not indicated** for the treatment of pertussis.
*that may cause a disulfiram-like reaction when taken with alcohol*
- This reaction (facial flushing, headache, nausea, vomiting) is typically caused by **metronidazole** or **cephalosporins with a methylthiotetrazole side chain**.
- These antibiotics are **not used** for the treatment of pertussis.
Question 69: A 29-year-old woman comes to the physician because of a 4-day history of fever with chills, nausea, myalgias, and malaise. One week ago, she returned from a trip to Rhode Island, where she participated in a month-long program to become an assistant park ranger. Laboratory studies show a leukocyte count of 1,400/mm3. A peripheral blood smear shows dark purple, mulberry-like inclusions inside the granulocytes. A presumptive diagnosis is made and pharmacotherapy is initiated with the drug of choice for this condition. The bacteriostatic effect of this drug is most likely due to inhibition of which of the following processes?
A. Bacterial peptidyl transferase activity at the 50S subunit
B. Bacterial topoisomerase II and topoisomerase IV activity
C. Binding of bacterial tRNA to the acceptor site of ribosomes (Correct Answer)
D. Transcription of bacterial DNA by RNA-polymerase
E. Peptidoglycan crosslinking and bacterial cell wall synthesis
Explanation: ***Binding of bacterial tRNA to the acceptor site of ribosomes***
This clinical presentation, including travel to an **endemic area** (Rhode Island), **fever, chills, myalgias, malaise, leukopenia**, and particularly the presence of **mulberry-like inclusions (morulae) in granulocytes**, is highly suggestive of **Anaplasmosis** caused by *Anaplasma phagocytophilum*.
The drug of choice for Anaplasmosis is **doxycycline**, a **tetracycline antibiotic**. Tetracyclines exert their **bacteriostatic effect** by **binding to the 30S ribosomal subunit**, thereby **preventing the attachment of aminoacyl-tRNA to the acceptor (A) site** and inhibiting bacterial protein synthesis.
*Bacterial peptidyl transferase activity at the 50S subunit*
Inhibition of bacterial **peptidyl transferase activity at the 50S ribosomal subunit** is the mechanism of action for **macrolides** (e.g., azithromycin, erythromycin) and **chloramphenicol**. While these are also bacteriostatic, they are not the first-line treatment for Anaplasmosis, and their ribosomal binding site differs from tetracyclines.
*Bacterial topoisomerase II and topoisomerase IV activity*
Inhibition of bacterial **topoisomerase II (DNA gyrase)** and **topoisomerase IV** is the mechanism of action for **fluoroquinolone antibiotics** (e.g., ciprofloxacin, levofloxacin). These drugs interfere with DNA replication and repair but are not the primary treatment for Anaplasmosis.
*Transcription of bacterial DNA by RNA-polymerase*
Inhibition of **bacterial RNA-polymerase** and thus bacterial DNA transcription is the mechanism of action for **rifampin**. Rifampin is primarily used for tuberculosis and some other infections, but not for Anaplasmosis.
*Peptidoglycan crosslinking and bacterial cell wall synthesis*
Inhibition of **peptidoglycan crosslinking** and bacterial **cell wall synthesis** is the mechanism of action for **beta-lactam antibiotics** (e.g., penicillins, cephalosporins) and **vancomycin**. These are generally bactericidal, and *Anaplasma* is an intracellular bacterium that lacks a peptidoglycan cell wall, rendering these antibiotics ineffective.
Question 70: A 13-year-old boy is brought to the emergency department because of a 2-day history of fever, headache, and irritability. He shares a room with his 7-year-old brother, who does not have any symptoms. The patient appears weak and lethargic. His temperature is 39.1°C (102.4°F) and blood pressure is 99/60 mm Hg. Physical examination shows several purple spots over the trunk and extremities. A lumbar puncture is performed. Gram stain of the cerebrospinal fluid shows numerous gram-negative diplococci. Administration of which of the following is most likely to prevent infection of the patient's brother at this time?
A. Penicillin G
B. Rifampin (Correct Answer)
C. Conjugated vaccine
D. Doxycycline
E. Cephalexin
Explanation: ***Rifampin***
- The patient has bacterial meningitis due to **Neisseria meningitidis**, identified by the gram-negative diplococci and classic symptoms (fever, headache, irritability, petechiae).
- **Rifampin** is commonly used for **chemoprophylaxis** against *N. meningitidis* in close contacts due to its excellent penetration into saliva and nasopharyngeal secretions, effectively eradicating carriage.
*Penicillin G*
- While **Penicillin G** is an effective treatment for established meningococcal meningitis, it is **not appropriate for prophylaxis** due to its poor penetration into respiratory secretions and its inability to reliably eradicate the nasopharyngeal carriage of *N. meningitidis*.
- Its use for prophylaxis would mainly target systemic infection rather than preventing transmission from a carrier state.
*Conjugated vaccine*
- The **meningococcal conjugated vaccine** provides active immunity against specific serogroups of *N. meningitidis*.
- However, it requires time for an immune response to develop and is therefore **not effective for immediate post-exposure prophylaxis** in a household contact.
*Doxycycline*
- **Doxycycline** is a broad-spectrum antibiotic but is **not the preferred agent for meningococcal prophylaxis**.
- Its primary uses include atypical bacterial infections, tick-borne diseases, and some sexually transmitted infections, rather than *N. meningitidis* chemoprophylaxis.
*Cephalexin*
- **Cephalexin** is a first-generation cephalosporin primarily used for skin and soft tissue infections and some urinary tract infections.
- It has **limited activity against *N. meningitidis*** and is not recommended for either treatment or prophylaxis of meningococcal disease.